New article published in Patient Safety & Quality Healthcare examining tissue dissemination risk in laparoscopic morcellation

A new article published in Patient Safety & Quality Healthcare examines tissue dissemination risk in laparoscopic morcellation and why this is no longer just a technical consideration in the OR.

When tissue fragmentation occurs without effective containment, the implications may extend beyond a single procedure, including potential cancer upstaging, benign tissue spread, and increased institutional liability.

At the same time, real-world practice remains variable:

• Differences in containment approaches across institutions

• Continued use of devices not specifically cleared for morcellation

• Inconsistent documentation and consent practices

Patients are increasingly informed and may revisit surgical decisions years later, asking:

• Was containment used?

• Was the system FDA-cleared?

As FDA-cleared containment options become available, expectations are shifting.

The question is no longer only how morcellation is performed, but how institutions evaluate, standardize, and govern containment practices.

We’re proud to contribute to this important conversation.

👉 Read the full article here.